 SOUTH SAN FRANCISCO, Calif., June 16, 2021 GLOBE NEWSWIRE -- Today, Annexon, Inc. Annexon Nasdaq: ANNX, a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, announced that Douglas Love, Esq., President Chief Executive Officer, will present at the virtual Raymond James Human Health Innovation Conference on June 23rd, 2021 at 1:20 pm EDT. 